Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development.

In conclusion, further development of the mH7 vaccine candidate is desirable.
PMID: 30857635 [PubMed - in process]

Source: Vaccine - March 13, 2019 Category: Allergy & Immunology Authors: Ting-Hui-Lin, Chia MY, Lin CY, Yeh YQ, Jeng US, Wu WG, Lee MS Tags: Vaccine Source Type: research